Read now on BioPharmInternational.com • January 11, 2019
Category: AbSci
AbSci teams up with global pharmaceutical company
Read now on Columbian.com • January 10, 2019
Biomanufacturing technologies maker AbSci collaborates with Sanofi
Read now on HealthcareOpportunity.org • January 10, 2019
AbSci establishes new collaboration with Sanofi
Read now on PRNewswire.com • January 9, 2019
AbSci appoints Andrew J.S. Jones, D. Phil to Scientific Advisory Board
Read now on PRNewswire.com • October 2, 2018
State’s 100 Best Companies to Work For announced
Read now on VBJUSA.com • July 13, 2018
AbSci aims to tackle the antibody market after raising $12m to scale E. coli-based tech
Read now on BioPharma-Reporter.com • June 20, 2018
AbSci raises oversubscribed $12M Series C to fuel commercialization of its groundbreaking protein expression platform
Read now on AbSci.com • May 30, 2018
Vancouver-based AbSci raises $12 million for research product
Read now on Columbian.com • May 30, 2018
Biomanufacturing company AbSci raises $12M to scale synthetic biology platform
Read now on GeekWire.com • May 30, 2018
Columbia Ventures Corporation 